A detailed history of Wallace Capital Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Wallace Capital Management Inc. holds 6,000 shares of ABT stock, worth $700,800. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$700,800
Previous $623,000 -0.0%
% of portfolio
0.1%
Previous 0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $4,599 - $5,080
-42 Reduced 0.7%
6,000 $681,000
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $608,912 - $678,456
6,042 New
6,042 $658,000
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $232,676 - $263,068
-4,135 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $53 - $57
1 Added 0.02%
4,135 $236,000
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $48 - $53
1 Added 0.02%
4,134 $221,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,133
4,133 $201,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wallace Capital Management Inc. Portfolio

Follow Wallace Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wallace Capital Management Inc. with notifications on news.